TRIPLE YOUR IMPACT during Triple Giving November | All Donations to OMF are TRIPLED through December 2
At Open Medicine Foundation (OMF), there is no research without patients, no breakthrough without their voices, and no hope without their courage. Every study we fund, every collaboration we build, every scientific question we pursue begins and ends with one
OMF’s biggest fundraising event is here—Triple Giving November (TGN)! From November 1 to December 2, every donation will be TRIPLED, up to $500,000, thanks to generous matching donors. This makes TGN our most impactful time of the year—when your support
This November, something special is returning — Triple Giving November (TGN)! Thanks to generous matching donors, every dollar you give to Open Medicine Foundation (OMF) will be TRIPLED, up to $500,000. To make sure more people can take part in
October is Dysautonomia Awareness Month and today, October 25th, we recognize POTS Awareness Day. Understanding Dysautonomia and POTS Dysautonomia is an umbrella term for a group of conditions that result from dysfunction of the autonomic nervous system (ANS)—the part of
October 9 is DAF Day—a national day dedicated to the power of Donor-Advised Funds (DAFs) to make a difference. This year, you can multiply your impact by directing a grant from your DAF to Open Medicine Foundation (OMF). To learn
What is Blinding? From the Desk of Dr. Danielle Meadows Vice President of Research Programs & Operations This month, I want to continue drilling down on some of the considerations that go into study design—the first stage of the research
OMF’s Collaborative Center at Montreal, in collaboration with our Collaborative Center at Uppsala and the Computational Research Center for Complex Diseases, has released a new paper: Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic
OMF’s Collaborative Center at Montreal, in collaboration with our Melbourne ME/CFS Collaboration, has released a new paper: Circulating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis. From the Desk of Dr. Alain Moreau, Director of
What is Proteomics? From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations Back in April, I elaborated a bit on what metabolomics is and how it’s used in ME/CFS research, as an important component of the
In August, OMF researchers from our collaborative centers at Stanford University and Montreal published a couple of papers investigating red blood cell movement and correlating a plasma marker to symptom profiles. I want to, of course, share these two publications
From the Desk of Dr. Danielle Meadows Vice President of Research Programs & Operations Back in December of 2024, we announced a new large-scale biomarker project for ME/CFS, which we’re calling BioQuest. I am thrilled to be able to share
As a mother, there is no greater calling than to care for your child—and when my daughter Amy fell ill with ME/CFS nearly eight years ago, I knew I would do whatever it took to support her. Watching her go
Get the latest updates delivered to your inbox.
What are the advantages of giving from your Donor Advised Fund (DAF)?
How do I make a donation through my DAF?
Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.
Still can’t find your fund?
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).Gifting of Stock
Broker: Schwab
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then email or call OMF at 650-242-8669 to notify us of your donation or with any questions.
